Other News To Note
Cytheris SA, of Paris, said a Phase IIa trial (INSPIRE-2) of CYT107 (recombinant interleukin-7) for reconstitution of CD4 T cells in chronic HIV-1 immunological nonresponder patients showed that the drug expanded those cells in the gut mucosa. The companys said it believes the drug may be able to restore the immune system in chronic HIV infection.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST